Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
The Life Sciences Report
Menu
Articles
Biotechnology / Pharmaceuticals
Cannabis
Healthcare Services
Life Sciences Tools & Diagnostics
Medical Devices
Nutraceuticals
Psychedelics
Disclosures
Featured news in
The Life Sciences Report
RXi Pharmaceuticals Corp.
(PHIO:NASDAQ)
RXi Pharmaceuticals to Present at Immuno-Oncology Frontiers World Conference (1/17/2018)
view
Celgene Corp.
(CELG:NASDAQ)
Biotech Stock Roundup: Juno Surges on Acquisition Rumor, Concert Down on Patent News (1/17/2018)
view
MiMedx Group Inc.
(MDXG:NASDAQ)
MiMedx Announces the Enrollment of the First Patients in the Phase 3 Clinical Trial of AmnioFix® Injectable for Achilles Tendonitis (1/17/2018)
view
RepliCel Life Sciences Inc.
(RP:TSX.V; REPCF:OTCQB)
RepliCel Life Sciences Lands Commitment for Key Investment Partnership (1/16/2018)
view
RXi Pharmaceuticals Corp.
(PHIO:NASDAQ)
RXi Pharmaceuticals Announces Business Strategy to Focus on Immuno-Oncology Programs to Accelerate Growth (1/16/2018)
view
Celgene Corp.
(CELG:NASDAQ)
Concert Pharmaceuticals Plunges on Patent Petition Setback (1/15/2018)
view
Celgene Corp.
(CELG:NASDAQ)
4 ETFs Set to Surge in Q4 Earnings (1/15/2018)
view
MiMedx Group Inc.
(MDXG:NASDAQ)
MiMedx Announces First Patients Have Been Enrolled In The Phase 3 Clinical Trial Of AmnioFix® Injectable In Patients With Recalcitrant Plantar Fasciitis Pain (1/16/2018)
view
BrainStorm Cell Therapeutics Inc.
(BCLI:NASDAQ)
BrainStorm to Present at Precision Medicine World Conference 2018 Silicon Valley on January 22 (1/16/2018)
view
ProMIS Neurosciences Inc.
(PMN:TSX; PMN:NCM)
Company's Therapy Attacks Only Harmful Brain Protein, Unlike Other Treatments, Study Finds (1/11/2018)
view